BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CSL
Carlisle Companies Incorporated
CSL has the edge over BA overall, supported by lower modeled downside and stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CSL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Stable |
CSL's revenue and profitability are currently healthy, and its cash flow and balance sheet are stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CSL in the historical PE scenario, which offers more potential upside but is not a forecast.
CSL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $258 | -34% |
| Forward | 17x | $393 | — |
| Fair | 20x | $351 | -11% |
| Current | 22x | $393 | — |
| Expensive | 26x | $459 | +17% |
Historical ranges are pointers, not guarantees.
CSL's PE is in its expensive range at 22x. If earnings grow as analysts expect, today's price would be 17x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
CSL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CSL, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over CSL on earnings, with more consistent year-over-year improvement.
CSL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $23.69 | +34% |
| Q3 2026 | $17.70 | -0.7% |
| Q2 2026 | $17.44 | -3.6% |
| Q1 2026 | $17.02 | -37% |
| Q4 2025 | $17.12 | -38% |
| Q3 2025 | $17.82 | -37% |
| Q2 2025 | $18.09 | -36% |
| Q1 2025 | $27.05 | +57% |
| Q4 2024 | $27.82 | +83% |
CSL's earnings per share have fallen from their peak: $17.70 over the past year, against $28.30 in mid-2024.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CSL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CSL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +8.6% |
| Q2 2026 | $1.6B | +8.3% |
| Q1 2026 | $1.1B | -4% |
| Q4 2025 | $1.1B | +0.4% |
| Q3 2025 | $1.3B | +1% |
| Q2 2025 | $1.4B | -0.1% |
| Q1 2025 | $1.1B | -0.1% |
| Q4 2024 | $1.1B | -0.4% |
CSL's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 8.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -1.8 points |
| Q2 2026 | 22% | -0.7 points |
| Q1 2026 | 17% | +0.4 points |
| Q4 2025 | 17% | -3.1 points |
| Q3 2025 | 22% | -1.9 points |
| Q2 2025 | 23% | -2.9 points |
| Q1 2025 | 17% | -3.8 points |
| Q4 2024 | 20% | -2.5 points |
CSL has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CSL on cash flow, with more consistent year-over-year improvement.
CSL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $277.3M | -30% |
| Q2 2026 | $200.1M | -23% |
| Q1 2026 | -$73M | -$45.8M |
| Q4 2025 | $346.1M | +3.6% |
| Q3 2025 | $393.4M | +34% |
| Q2 2025 | $258.3M | +63% |
| Q1 2025 | -$27.2M | -121% |
| Q4 2024 | $334M | -5.4% |
CSL still generates free cash flow, though less than at its 2023 peak: $751M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CSL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.2% | -900K shares |
| 1 year | -7.7% | -3.3M shares |
| 3 years | -21% | -10.5M shares |
| 5 years | -25% | -13.4M shares |
| Available history | -31% | -17.9M shares |
CSL has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $350M |
| Q2 2026 | $250M |
| Q1 2026 | $250M |
| Q4 2025 | $300M |
| Q3 2025 | $300M |
| Q2 2025 | $300M |
| Q1 2025 | $400M |
| Q4 2024 | $419.8M |
CSL spent $1.1B buying back its own shares over the past year, down 19% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CSL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.5x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 0.9x | Very low |
CSL has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CSL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.2 | Neutral |
| Stochastic | 76.1 | Neutral |
CSL's weekly RSI is 61 (neutral) and its Stochastic is 76 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CSL on valuation relative to its sector.
CSL PE vs Industrials Sector
| Metric | CSL | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 24x | 7.7% below |
| PE % | 67 | 58 | 9 pts above |
CSL is trading at 22x earnings, in line with the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CSL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $350.0 | 12% above |
| 20 week MA | $351.1 | 12% above |
| 50 week MA | $352.1 | 11% above |
| 100 week MA | $357.0 | 10% above |
| 200 week MA | $341.9 | 15% above |
CSL has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CSL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $163.0 | $157.4 | -3.5% |
| 2021 | $157.4 | $240.8 | +53% |
| 2022 | $240.8 | $237.9 | -1.2% |
| 2023 | $237.9 | $312.4 | +31% |
| 2024 | $312.4 | $372.0 | +19% |
| 2025 | $372.0 | $330.3 | -11% |
| 2026 YTD | $330.3 | $392.6 | +19% |
CSL has the edge over BA on returns for 2026, with the stronger performance.